Abdominal Organ Transplant

Description

Scientific objectives and lines of work

1. Liver transplantation with grafts from an uncontrolled asystolic donor.
   • Biliary complications
   • Liver transplantation with grafts from an asystolic donor (type 3) receiving extracorporeal membrane oxygenation (ECMO)
2. Immunosupression.
   • Monotherapy with mycophenolate mofetil (MMF). Comparison between MMF in monotherapy and the mammalian target of rapamycin (m-TOR) in monotherapy in liver transplantations. Comparison between sirolimus in monotherapy and everolimus in monotherapy
3. Long-term results in liver transplantations for alcoholic cirrhosis.
4. Liver transplantation with elderly donors.
5. Liver transplantation due to hepatocarcinoma. Comparison between the Milan criteria and the Expanded criteria. Liver transplantation due to intrahepatic cholangiocarcinoma.
6. De novo tumors of the upper aerodigestive tract in liver transplant receptors.
7. Simultaneous hepatorenal transplantation compared to a renal transplantation following a liver transplantation. Simultaneous hepatorenal transplantation in hepatorenal polycystosis.
8. Hepatic abscesses following a liver transplantation.
9. Simultaneous pancreatico-renal transplantation (SPRT).
   • Causes and risk factors for loss of the pancreatic graft in SPRT
   • Risk factors for pancreatic graft thrombosis in SPRT
   • Incidence and risk factors for duodenal fistulae in SPRT
   • Risk factors for abdominal infections following a SPRT
   • Results of pancreatico-renal transplantations under hemodialysis versus peritoneal dialysis
   • Results of pancreatico-renal transplantations with exocrine derivation
   • Results of pancreatico-renal transplantations with Belzer solution versus Celsior solution
   • Use of an annular pancreatic graft in pancreas transplantations